Health
Members Health Calls for National Reform to Strengthen Healthcare and Bolster Economic Prosperity and Social Wellbeing
MELBOURNE, Australia, Oct. 16, 2024 /PRNewswire/ -- Members Health is calling for major reforms to boost health care accessibility and affordability and improve transparency of hospitals and doctors acrossAustralia as part of a landmark report released today for the not-for-profit health insuranc...
2024-10-16 06:12
1388
Cardiex Awarded $525,000 Grand Prize in NIH RADx Tech for Maternal Health Challenge
SYDNEY, Oct. 16, 2024 /PRNewswire/ -- Cardiex, a global health technology company specializing in cardiovascular diagnostics and devices, today announced it has been awarded the$525,000 grand prize in the US National Institutes of Health (NIH) RADx Tech for Maternal Health Challenge. The award re...
2024-10-16 06:00
1971
AtomVie Global Radiopharma and Radiopharm Theranostics Partner to Develop and Manufacture 177Lu-BetaBart Radioantibody for Treatment of Multiple Solid Tumors
HAMILTON, ON, Oct. 16, 2024 /PRNewswire/ -- AtomVie Global Radiopharma (AtomVie), a leading radiopharmaceutical Contract Development and Manufacturing Organization (CDMO), has entered into an agreement with Radiopharm Ventures (RV), a Joint Venture between Radiopharm Theranostics (RAD) and MD And...
2024-10-16 05:00
926
PharmAust affirms corporate strategy with name change to Neurizon Therapeutics
MELBOURNE, Australia, Oct. 15, 2024 /PRNewswire/ -- Neurizon Therapeutics Limited (ASX: NUZ) ("Neurizon" or "the Company"), a clinical-stage biotech company dedicated to advancing treatments for neurodegenerative diseases, is pleased to announce it has officially changed its name from PharmAust L...
2024-10-16 04:14
1243
MDisrupt Secures American Heart Association Ventures Investment, Enters Strategic Collaboration for Association Members
* American Heart Association Ventures invests in MDisrupt * Lisa Suennen, Managing Partner of American Heart Association Ventures and longtime healthcare veteran, joins the MDisrupt board * MDisrupt's marketplace will be made available to thousands of the American Heart Association's profe...
2024-10-16 03:00
1360
RLDatix Appoints Dan Michelson as Chief Executive Officer
Michelson succeeds Jeff Surges who transitions into Board Advisor Role CHICAGO, Oct. 16, 2024 /PRNewswire/ -- RLDatix, a leading global provider of connected healthcare operations software and services, announced today the appointment ofDan Michelson as its new Chief Executive Officer and a membe...
2024-10-15 23:28
1127
Chiglitazar for the Treatment of MASH Phase II Clinical Study Selected for Oral Presentation at the 2024 American Liver Disease Annual Meeting
SHENZHEN, China, Oct. 15, 2024 /PRNewswire/ -- On October 15, 2024, the list of selected candidates for the oral report of the American Association for the Study of the Liver (AASLD 2024) annual meeting was officially announced online. The abstract of the Phase II clinical study (CGZ203 trial) on...
2024-10-15 22:08
1346
Accure Acne Announces New FDA Clearance for the Long-Term Treatment of Acne
The Groundbreaking Accure Laser System is now indicated for the long-term treatment of mild to severe inflammatory acne vulgaris BOULDER, Colo., Oct. 15, 2024 /PRNewswire/ -- Accure Acne, Inc.™ ( www.accureacne.com), a pioneer in the development of innovative solutions for the treatment of acne, ...
2024-10-15 21:50
1036
Operation Smile Featured in "Beyond the Code," a New Branded Series that Explores How AI Is Driving Transformative Change
VIRGINIA BEACH, Va., Oct. 15, 2024 /PRNewswire/ -- Global nonprofit Operation Smile today announced its involvement in Beyond the Code, a new branded series presented by Partnership onAI (PAI) and produced by BBC StoryWorks Commercial Productions. The first of its kind, this online series – which...
2024-10-15 21:00
984
Bloomage Debuts New Products at CPHI Milan to Reinforce Its Commitment to Innovation
MILAN, Oct. 15, 2024 /PRNewswire/ -- Bloomage, a global leader in hyaluronic acid and other bioactive substance innovations, unveiled its Hyatrue® Sterile Sodium Hyaluronate (HA) and showcased its BloomseaN™ Polydeoxyribonucleotide (PDRN) and Polynucleotide (PN) at CPHI Milan. Known to be at "the...
2024-10-15 21:00
749
Neurophet-AriBio to develop 'Next-Gen Platform for Alzheimer's diagnosis'
- Neurophet's brain MRI analysis technology incorporates fluid biomarker data from AriBio's global Phase 3 clinical trial for Alzheimer's disease - Collaborates leveraging Neurophet's medical image analysis technology and AriBio's clinical trial data analysis expertise SEOUL, South Korea, Oct. 1...
2024-10-15 21:00
1208
Prenetics Announces Tencent's US$30 Million Investment in Insighta, Strengthening Strategic Partnership for AI-Driven Early Cancer Detection
HONG KONG, Oct. 15, 2024 /PRNewswire/ -- Prenetics Global Limited (NASDAQ: PRE), a leading health sciences company, today announced thatTencent has made a strategicUS$30 million investment in Insighta, a Hong Kong-based early cancer detection company. This investment values Insighta atUS$200 mill...
2024-10-15 20:50
3533
Gan & Lee Pharmaceuticals' Three Innovative Drugs: GZR18 Injection, GZR4 Injection, and GZR101 Injection Achieve Primary Endpoints in Phase 2 Clinical Studies
* After 24 weeks of treatment in patients with Type 2 diabetes, the bi-weekly GLP-1 receptor agonist GZR18 injection showed superior efficacy in lowering HbA1c and body weight compared to semaglutide (Ozempic®). * After 16 weeks of treatment in patients with Type 2 diabetes, the once-weekly i...
2024-10-15 19:36
1177
Endogenex™ Announces First Patient Enrolled in the ReCET Clinical Study
Achieving a Significant Clinical Milestone in Assessing the ReCET™ System as a Groundbreaking Treatment for Type 2 Diabetes MINNEAPOLIS, Oct. 15, 2024 /PRNewswire/ -- Endogenex, Inc., a clinical-stage medical device company focused on improving outcomes for patients with type 2 diabetes (T2D), t...
2024-10-15 19:32
931
Empowering Experience through Digital, Humanizing Technology for All: vivo Unveils Vision in the Future of Mobile Imaging at the Global Imaging Press Conference
BEIJING, Oct. 15, 2024 /PRNewswire/ -- vivo, a global leader in mobile technology, successfully convened the 2024 vivo Global Imaging Press Conference inBeijing today, bringing together over 100 global media representatives. Following the unveiling of the latest vivo X200 series, the conference e...
2024-10-15 17:51
1256
Fapon showcases its total IVD solutions at Hospital Expo to empower local Indonesian IVD industry
DONGGUAN, China, Oct. 15, 2024 /PRNewswire/ -- Fapon, a global leading life sciences company, is excited to participate in the Hospital Expo inJakarta, Indonesia, from October 16 – 19. Fapon will showcase its total IVD solutions, including IVD raw materials, reagent services and open-system instr...
2024-10-15 16:28
1315
Clarivate Repeats Success in Nobel Prize Predictions with Eight New Winners Identified by Citation Laureates Program
83 Citation Laureates named by the Institute for Scientific Information have received a Nobel Prize since 2002 LONDON, Oct. 15, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the success of its annualCitation Laureates™ p...
2024-10-15 15:00
1093
DBN Group Invites Global Agricultural Biotech Companies to Co-create a Leading Innovation Ecosystem at DBN Phoenix International Innovation Park
BEIJING, Oct. 15, 2024 /PRNewswire/ -- DBN Group
2024-10-15 13:45
1584
Aidoc and Integral Diagnostics (IDX) Expand AI Partnership in Australia and New Zealand
Aidoc's AI technology enhances radiology services at IDX, significantly improving patient care and service and well-placed to support the upcoming National Lung Cancer Screening Program. MELBOURNE, Australia, Oct. 15, 2024 /PRNewswire/ -- Aidoc, a global pioneer in clinical AI solutions, today a...
2024-10-15 11:28
1169
PharmAbcine Announces Safety Approval for 4mg Single-dose Cohort in Phase 1 Clinical Trial of PMC-403 for Neovascular Age-related Macular Degeneration
* Safety Review Committee (SRC) approves single ascending dose 4mg cohort in Phase 1 trial of PMC-403, preparing for multiple ascending dose 4 mg cohort. * PMC-403 is being explored in broader therapeutic areas, including rare vascular disease systemic capillary leak syndrome (SCLS) and kidney...
2024-10-15 09:51
1211
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 313 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Strategic Forum in Chongqing Drives Expansion of New Western Land-Sea Corridor
2024-11-16 14:15
5201
